Name: | Recombinant full length human γ-synuclein |
HGNC Name: | SNCG |
RRID: | NA |
Format: | 1mg/mL in 6M Urea |
Applications: | Western blotting, ELISA and antibody production |
Storage: | Store at -20°C |
Uniprot: | O76070 |
Human γ-Synuclein Protein, Cat# Prot-r-SNCG
$300.00 – $2,000.00
γ-synuclein is a member of the synuclein family, the other two proteins being α and β-synuclein. α-synuclein was originally isolated as a major synaptic vesicle associated protein from the electric organ of the electric fish Torpedo and was independently discovered as a protein copurifying with amyloid fibrils of Alzheimer’s disease. Further work showed that α-synuclein is a major component of the Lewy bodies of Parkinson’s disease and accumulates in the brains of patients with multiple system atrophy and amyotrophic lateral sclerosis (1-3). The related protein γ-synuclein is also implicated in CNS and and other disorders and was originally isolated by screening for proteins expressed preferentially in the peripheral nervous system. As a close relative of α-synuclein it was named “persyn” for peripheral synuclein (4). It was also independently isolated and named “breast carcinoma specific gene 1 (BCSG1)”, since it was heavily expressed in breast carcinoma but not in healthy breast tissue (5,6).
A codon optimized cDNA encoding full length human γ-synuclein was designed and inserted into the pET30a(+) expression vector. The vector adds an N-terminal His-tag, S-tag and proteolytic cleavage sites to the human sequence which increases the molecular weight by about 5kDa. The construct was expressed by standard methods in E. coli and purified using a Nickel column in 6M urea. The protein is supplied in 6M urea in phosphate buffer. The lane on the far left contains protein standards of the indicated molecular size. In the next lanes 2µg, 1µg and 0.5µg of the recombinant γ-synuclein were run as indicated and 1µg and 0.5µg of BSA were in the two right lanes.
Human γ-synuclein sequence was based on that was NP_003078.2 which was inserted into the eukaryotic expression vector pET30a(+) which adds an N-terminal His-tag and some other sequence, underlined below. This sequence includes a thrombin cleavage site (blue), an S-tag affinity peptide (red) and an enterokinase cleavage site (green).
MHHHHHHSSG LVPRGSGMKE TAAAKFERQH MDSPDLGTDD DDKAMADIGS EFMDVFKKGF 60
SIAKEGVVGA VEKTKQGVTE AAEKTKEGVM YVGAKTKENV VQSVTSVAEK TKEQANAVSE 120
AVVSSVNTVA TKTVEEAENI AVTSGVVRKE DLRPSAPQQE GEASKEKEEV AEEAQSGGD 179
Number of amino acids: 179
Molecular weight: 19039.01
Theoretical pI: 5.12
Amino acid composition:
Ala (A) 21 11.7%
Arg (R) 4 2.2%
Asn (N) 4 2.2%
Asp (D) 10 5.6%
Cys (C) 0 0.0%
Gln (Q) 7 3.9%
Glu (E) 23 12.8%
Gly (G) 15 8.4%
His (H) 7 3.9%
Ile (I) 3 1.7%
Leu (L) 3 1.7%
Lys (K) 18 10.1%
Met (M) 6 3.4%
Phe (F) 4 2.2%
Pro (P) 4 2.2%
Ser (S) 15 8.4%
Thr (T) 12 6.7%
Trp (W) 0 0.0%
Tyr (Y) 1 0.6%
Val (V) 22 12.3%
Total number of negatively charged residues (Asp + Glu): 33
Total number of positively charged residues (Arg + Lys): 22
Extinction coefficients:
This protein does not contain any Trp residues. Experience shows that
this could result in more than 10% error in the computed extinction coefficient.
Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water.
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 0.078
1. Maroteaux, L., Campanelli, JT and Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8:2804-2815 (1988).
2. Lavedan, C. The Synuclein Family. Genome Research 8:871-880 (1998).
3. Polymeropoulos, MH et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276: 2045-2047 (1997).
4. Buchman, VL et al. Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System. J. Neurosci. 8:9335-9341 (1998)
5. Ji H, et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57:759–64 (1997).
6. Bruening, W. et al. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88:2154-63 (200).
Related products
-
Recombinant Human Peripherin
$300.00 – $2,000.00
Cat# Prot-r-PeriSelect options This product has multiple variants. The options may be chosen on the product page -
Human α-Synuclein Protein,
$300.00 – $2,000.00
Cat# Prot-r-SNCASelect options This product has multiple variants. The options may be chosen on the product page -
Human MAP2 Projection P3
$300.00 – $2,000.00
Cat# Prot-r-MAP2A/B-P3Select options This product has multiple variants. The options may be chosen on the product page -
Recombinant ACE2 SARS-CoV2 Binding Domain
$300.00 – $2,000.00Select options This product has multiple variants. The options may be chosen on the product page
Contact info
EnCor Biotechnology Inc.
4949 SW 41st Boulevard, Ste 40
Gainesville
Florida 32608 USA
Phone: (352) 372 7022
Fax: (352) 372 7066
E-mail: admin@encorbio.com